A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium
| Image |  |
|---|---|
| Description | scientific article published on January 26, 2013 |
| Author/s |
author: Masoom A Haider Ian F. Tannock |
| Publication date | January 26, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://link.springer.com/content/pdf/10.1007/s10637-013-9931-1.pdf |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |